Tuberculosis/HIV Co-infection among Internally Displaced Persons (IDP) in Gombe State, Nigeria
South Asian Journal of Research in Microbiology,
Background: Tuberculosis is a global health problem associated with high morbidity and mortality. Rapid diagnosis of tuberculosis is essential for early disease management. Human Immunodeficiency Virus (HIV) is a virus that gradually attacks the immune system and the immune system is our body’s natural defence against illness. Co-infection of TB and HIV is when someone has both HIV and TB infections. This study determined the TB/HIV Co-infection among IDP’s.
Result: Fifty-nine patients 59(45.4%) were males and seventy-one 71 patients (54.6%) were females. Seventeen patients (13.07%) had tuberculosis. Ten (10) cases of the TB patients were found to be co-infected with HIV. The CD4+ cell count of the TB/HIV co-infected patients falls below 250 cells/mm3 compared to the mono-infected patients who had CD4+ above 250 cells/mm3.
Conclusion: This study showed that TB/HIV coinfection was associated with age group 21-40 years was high.
- CD4 cells IDP and Gombe State.
How to Cite
Ferri FF. Ferri's differential diagnosis: A practical guide to the differential diagnosis of symptoms, signs, and clinical disorders (2nd ed.). Philadelphia, PA: Elsevier/ Mosby. 2010;576.
Nwanjo HU, Oze GO. Oxidative imbalance and non-enzymic antioxidant status in pulmonary tuberculosis infected subjects: Carcinogenic potential. Pakistan Journal of Nutrition. 2007;6(6):590-592.
Gopi PG, Subramani V, Chandra S, Santha T, Narayana PR. Indian Journal of Tuberculosis. 2008;55:22-27.
Swaminathan S, Padmapriyadarsini C, Sugumar B. Nutritional status of person with HIV infection, tuberculosis and HIV negative individuals from Southern India. Clinical Infectious Disease. 2008;46(94): 6-948.
Sultan KM, Alobaidy MW, AL-Jubouri AM, Nase AA, AL-Sabah HA. Assessment of body mass index and nutritional status in pulmonary tuberculosis patients. Journal of Faculty of Medicine Baghdad. 2012;54:3.
Waiid IS, Edmen T, Hoal EG. Total antioxidants levels are low during active TR and rise with anti-tuberculosis therapy. International Union of Biochemistry and Molecular Biology Life. 2004;56(2):101-106.
Smith I. Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence Clinical Microbiology Review. 2003;16(3):463-96.
World Health Organization. World Health Organization Report Global Tuberculosis Control, Country Profiles; 2012a.
World Health Organization. Global tuberculosis report. Geneva. 2012b;55.
Funke JD. Mathematical Epidemiology of HIV/AIDS and Tuberculosis Co-Infection; 2013.
Mayer K. Synergistic pandemics: Confronting the global HIV and tuberculosis epidemics, Clinical infectious Diseases. 2010;50:3.
Kendal MA, Havlir D. Timing of antiretroviral therapy and TB. Analysis of a Dynamical Model for Transmission of Tuberculosis with a General Content; 2011.
World Health Organization. Xpert MTB/RIF implementation manual: Technical and Operational How-to, Practice; 2014.
Fryland M. Chaillet P. Zachariah R. Barnaba A. Bonte L, Didakus O. The partec cyflow counter could provide and option for CD 4 T-cell monitoring in the context of scaling up antiretroviral treatment at the district level in Malawi. The Royal Society of Tropical Medicine and Hygiene. 2006;100(10):980-985.
Bio-rad. A qualitative assay for the confirmation and differentiation of individual antibodies to hiv-1 and hiv-2 in whole blood, serum, or plasma specimens; 2013.
Okonkwo P, Odaibo G, Lawal D, Olaleye D. HIV infection among newly diagnosed TB patients in Southwestern Nigeria: A multi-dots center study. World Journal of AIDS. 2013;(2):154-159.
Sani RA, Garba SA, Oyeleke SB, Moses EA. Prevalence of pulmonary tuberculosis (PTB) in Minna and Suleja, Niger State. American Journal of Medicine and Medical Sciences. 2015;5(6):27-291.
Nwachukwu NC, Orgi A Kanu, Okereke HC. Epidemiology of pulmonary tuberculosis in some parts of Abia state. Asian Journal of Epidemiology. 2009;2: 13-19.
Olusola A. Adejumo Olusoji, Daniel J, Adetokunbo Dacosta. Factors associated with TB/HIV co-infection among drug sensitive TB patients managed in a secondary health facility in Lagos, Nigeria. African Journal of Infectious Disease. 2017;11(2):75-82.
Oyebuchi S Ofoegbu, Bethrand B Odume. Treatment outcome of TB patients of National Hospital Abuja, Nigeria. A five-year retrospective study. South African Family Practice. 2014;57(1): 50-56.
Agbaji O, Ebonyi AO, Meloni ST, Anejo-Okopi JA, Akanbi MO. Factors associated with pulmonary tuberculosis-HIV co-infection in treatment-naive adults in Jos, North Central Nigeria. Journal of AIDS and Clinical Research. 2013;4: 222.
Abstract View: 49 times
PDF Download: 31 times